Rafferty Asset Management
COLL icon

Rafferty Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Rafferty Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,785
Closed -$222K – 1080
2025
Q4 		$222K Buy
+4,785
New +$200K ﹤0.01% 1075
2024
Q4 		– Sell
-6,225
Closed -$241K – 1148
2024
Q3 		$241K Sell
6,225
-81
-1% -$2.89K ﹤0.01% 1070
2024
Q2 		$203K Buy
+6,306
New +$219K ﹤0.01% 1139

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Rafferty Asset Management's COLL Position: Q1 2026 in Review

Rafferty Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 4,785 shares — an estimated $222K sold.

Rafferty Asset Management first reported a position in COLL in Q2 2024 and held it in 3 quarters. The position peaked at $241K in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Rafferty Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 4,785 Collegium Pharmaceutical shares in Q1 2026, an estimated $222K.
  • Rafferty Asset Management first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 3 quarters.
  • Rafferty Asset Management's Collegium Pharmaceutical position peaked at $241K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.